Stay updated on Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for this phase I study of M7824 with radiation therapy in metastatic hormone receptor-positive, HER2-negative breast cancer is displayed, including its study design, participant criteria, and measures. The record indicates that the study is completed and is no longer recruiting.SummaryDifference48%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH banner announces transition updates and FAQs, stating that NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page now returns a 403 Forbidden error, blocking access to the study details. The previous content has been removed and replaced by a 403 message with the site header/footer visible.SummaryDifference19%

Stay in the know with updates to Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page.